Survodutide Research Compound (SUR)

"Premium grade Survodutide validation."

Survodutide (BI 456906) is a synthetic dual glucagon and GLP-1 receptor agonist studied in metabolic pathway research. A phase 2 dose-finding trial reported dose-dependent reductions in body weight in adults with overweight or obesity (le Roux et al., Lancet Diabetes Endocrinol 2024, PMID 38330987). Survodutide research peptide is supplied lyophilized at ≥99% purity verified by HPLC, with identity confirmed by mass spectrometry and a batch-specific Certificate of Analysis (COA) included. Store lyophilized powder at −20 °C, protected from light and moisture. For laboratory research use only — not for human or animal consumption.